The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Vishwakarma R, AlFaifi M, Alsohimi S, Alrayes A, Albishi S, Alqahtani R, Alalawi M, Al Sulaihim I, Alanazi TA, Alqahtani RA, Almagthali A, Jomah S, Alshlowi A, Alshammari TR, Alzahrani SS, Abdulqader MI.
Al Sulaiman K, et al. Among authors: alshammari tr.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216.
Clin Appl Thromb Hemost. 2023.
PMID: 38073058
Free PMC article.